Abstract
Concern is continuing about increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids. The aim of this work is to present a few results from the literature about this problem.
MeSH terms
-
Administration, Inhalation
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / adverse effects*
-
Humans
-
Meta-Analysis as Topic
-
Pneumonia / epidemiology*
-
Pulmonary Disease, Chronic Obstructive / drug therapy*
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Risk Factors
-
Time Factors